Evidence map›Paper›PMID 41625476›Full record

Trial reportCancer communications (London, England)2026

Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China.

Xiaowen Liu, Jiejie Jin, Menglong Zhou, Ye Zhou, Hong Cai, Hua Huang, Min Yan, Zhongyin Yang, Runhua Feng, Qi Lu and 9 more

Abstract readClinical Trial, Phase IIIRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xiaowen LiuDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Jiejie JinDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Menglong ZhouDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Ye ZhouDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Hong CaiDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Hua HuangDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Min YanDepartment of Gastrointestinal Surgery, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory of Stomach Neoplasm, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China.
Zhongyin YangDepartment of Gastrointestinal Surgery, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory of Stomach Neoplasm, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China.
Runhua FengDepartment of Gastrointestinal Surgery, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory of Stomach Neoplasm, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China.
Qi LuDepartment of Surgery, Huadong Hospital, Fudan University, Shanghai, P. R. China.
Hao DingDepartment of Surgery, Huadong Hospital, Fudan University, Shanghai, P. R. China.
Hongtao XuDepartment of Surgery, Zhejiang Lishui Central Hospital, Lishui, Zhejiang, P. R. China.
Xuexiao LiuDepartment of Radiotherapy, Zhejiang Lishui Central Hospital, Lishui, Zhejiang, P. R. China.
Guichao LiDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Hui ZhuDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Weiqi ShengDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Xiujiang YangDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Zhen ZhangDepartment of Oncology, Shanghai Medical College of Fudan University, Shanghai, P. R. China.
Yanong WangDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.ORCID https://orcid.org/0000-0002-7405-5229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyEsophageal NeoplasmsEsophagogastric JunctionStomach NeoplasmsAdultAgedChinaDisease-Free SurvivalDrug CombinationsFemaleHumansMaleMiddle AgedNeoadjuvant TherapyDrug CombinationsOxaliplatinOxonic AcidS 1 (combination)Tegafur

Identifiers

PMID41625476
PMCPMC12857758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.